Related Experiment Video
Updated: Aug 19, 2026

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
Induction of prosurvival molecules by apoptotic stimuli: involvement of FOXO3a and ROS
Jun-Wei Liu1, Dhyan Chandra, Michael D Rudd
1Department of Carcinogenesis, the University of Texas MD Anderson Cancer Center, Science Park-Research Division 1C, Smithville, TX 78957, USA.
Abstract:
Most cancer therapeutics fails to eradicate cancer because cancer cells rapidly develop resistance to its proapoptotic effects. The underlying mechanisms remain incompletely understood. Here we show that three representative apoptotic stimuli, that is, serum starvation, a mitochondrial toxin, and a DNA-damaging agent (etoposide), rapidly induce several distinct classes of prosurvival molecules, in particular, Bcl-2/Bcl-X(L) and superoxide dismutase (SOD; including both MnSOD and Cu/ZnSOD). At the population level, the induction of these prosurvival molecules occurs prior to or concomitant with the induction of proapoptotic molecules such as Bim and Bak. Blocking the induction using siRNAs of the prosurvival or proapoptotic molecules facilitates or inhibits apoptosis, respectively. One master transcription factor, FOXO3a, is involved in the transcriptional activation of some of these prosurvival (e.g., MnSOD) and proapoptotic (e.g., Bim) molecules. Interestingly, in all three apoptotic systems, FOXO3a itself is also upregulated at the transcriptional level. Mechanistic studies indicate that reactive oxygen species (ROS) are rapidly induced upon apoptotic stimulation and that ROS inhibitors/scavengers block the induction of FOXO3a, MnSOD, and Bim. Finally, we show that apoptotic stimuli also upregulate prosurvival molecules in normal diploid human fibroblasts and at subapoptotic concentrations. Taken together, these results suggest that various apoptotic inducers may rapidly mobilize prosurvival mechanisms through ROS-activated master transcription factors such as FOXO3a. The results imply that effective anticancer therapeutics may need to combine both apoptosis-inducing and survival-suppressing strategies.
Insights
Cancer cells resist apoptosis by upregulating prosurvival molecules like Bcl-2/Bcl-X(L) and superoxide dismutase (SOD). This survival mechanism, activated by reactive oxygen species (ROS) and transcription factor FOXO3a, hinders cancer therapeutics.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Cancer therapeutics often fail due to rapid development of resistance by cancer cells to proapoptotic effects.
- The precise mechanisms underlying this resistance are not fully understood.
- Identifying these mechanisms is crucial for developing more effective cancer treatments.
Purpose of the Study:
- To investigate the rapid induction of prosurvival molecules in response to apoptotic stimuli.
- To elucidate the role of transcription factor FOXO3a and reactive oxygen species (ROS) in this process.
- To explore potential strategies for overcoming therapeutic resistance in cancer.
Main Methods:
- Induction of apoptosis using serum starvation, a mitochondrial toxin, and etoposide.
- Analysis of prosurvival (Bcl-2/Bcl-X(L), SOD) and proapoptotic (Bim, Bak) molecule expression.
- Utilized siRNAs to block molecule induction and assess effects on apoptosis.
- Investigated the role of transcription factor FOXO3a and ROS using inhibitors/scavengers.
Main Results:
- Apoptotic stimuli rapidly induced prosurvival molecules (Bcl-2/Bcl-X(L), SOD) before or concurrently with proapoptotic molecules (Bim, Bak).
- FOXO3a was identified as a master transcription factor involved in regulating both prosurvival and proapoptotic molecules, and was itself upregulated.
- Reactive oxygen species (ROS) were rapidly induced and found to mediate the upregulation of FOXO3a, MnSOD, and Bim.
- Prosurvival mechanisms were also activated in normal fibroblasts and at subapoptotic concentrations.
Conclusions:
- Apoptotic stimuli rapidly activate prosurvival mechanisms via ROS-dependent pathways involving transcription factor FOXO3a.
- Cancer cells and normal cells mobilize survival strategies in response to apoptotic triggers.
- Effective anticancer therapeutics may require combined strategies targeting both apoptosis induction and survival suppression.
Related Concept Videos
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Apoptosis
PI3K/mTOR/AKT Signaling Pathway
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
